Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000951819 | SCV001098258 | likely benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2024-10-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002547225 | SCV003683025 | uncertain significance | Inborn genetic diseases | 2024-03-28 | criteria provided, single submitter | clinical testing | The c.6721G>A (p.G2241R) alteration is located in exon 35 (coding exon 34) of the CACNA1H gene. This alteration results from a G to A substitution at nucleotide position 6721, causing the glycine (G) at amino acid position 2241 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |